SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GIPL

Global Innovative Platforms Inc. (OTC:GIPL)

US · Delayed Price · Currency is USD
Technology · Information Technology Services
$0.05+$0.00 (+0.00%)
 
Market cap
$2.54M
Insider Score
Health Score
Listed since
Dec 23, 2003
Market Cap$2.54M-54.0%
Revenue (ttm)$187.20K+56.7%
Net Income-$677.04K-101.4%
EPS-$0.01-0.0%
Shares Out49.75M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,946
Open$0.05
Previous Close$0.05
Day's Range$0.05 - $0.50
52-Week Range$0.05 - $0.99
Beta5.16
Analystsn/a
Price Targetn/a
Earnings Daten/a
No price history available.

About GIPL

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.

Address
570 Lexington, Green Ln, Sanford, FL, 32771, US
Market Cap
3 million
Employees
1
Industrial Classification
Information Technology Services

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$1.25K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From GIPL’s reported statements · Q2 2026 (trailing 12 months)
1 Day
+0.00%
5 Days
-49.00%
1 Month
-89.80%
6 Months
-89.80%
1 Year
-54.05%

$GIPL stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in GIPL holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by GIPL's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

GIPL Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New GIPL patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to GIPL from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from GIPL’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
20
Sells
0
Buy Value
$1.25K
Distinct Buyers
2

Insider Score Trend Over Time

+0.0 since Sep 10
0255075100Sep 10 — Insider Score 0.0Sep 11 — Insider Score 0.0Sep 12 — Insider Score 0.0Sep 13 — Insider Score 0.0Sep 14 — Insider Score 0.0Sep 15 — Insider Score 0.0Sep 16 — Insider Score 0.0Sep 17 — Insider Score 0.0Sep 18 — Insider Score 0.0Sep 19 — Insider Score 0.0Sep 20 — Insider Score 0.0Sep 21 — Insider Score 0.0Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 47.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 10Sep 22Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.